The MJNA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the MJNA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The MJNA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View MJNA Detailed Price Forecast - CNN Money||View MJNA Detailed Summary - Google Finance|
|View MJNA Detailed Summary - Yahoo! Finance||View MJNA Stock Research & Analysis - Zacks.com|
|View MJNA Trends & Analysis - Trade-Ideas||View MJNA Major Holders - Barrons|
|View MJNA Call Transcripts - NASDAQ||View MJNA Breaking News & Analysis - Seeking Alpha|
|View MJNA Annual Report - CompanySpotlight.com||View MJNA OTC Short Report - OTCShortReport.com|
|View MJNA Fundamentals - TradeKing||View MJNA SEC Filings - Bar Chart|
|View Historical Prices for MJNA - The WSJ||View Performance/Total Return for MJNA - Morningstar|
|View the Analyst Estimates for MJNA - MarketWatch||View the Earnings History for MJNA - CNBC|
|View the MJNA Earnings - StockMarketWatch||View MJNA Buy or Sell Recommendations - MacroAxis|
|View the MJNA Bullish Patterns - American Bulls||View MJNA Short Pain Metrics - ShortPainBot.com|
|View MJNA Stock Mentions - StockTwits||View MJNA Stock Mentions - PennyStockTweets|
|View MJNA Stock Mentions - Twitter||View MJNA Investment Forum News - Investor Hub|
|View MJNA Stock Mentions - Yahoo! Message Board||View MJNA Stock Mentions - Seeking Alpha|
|View Insider Transactions for MJNA - SECform4.com||View Insider Transactions for MJNA - Insider Cow|
|View MJNA Major Holdings Summary - CNBC||View Insider Disclosure for MJNA - OTC Markets|
|View Insider Transactions for MJNA - Yahoo! Finance||View Institutional Holdings for MJNA - NASDAQ|
|View MJNA Stock Insight & Charts - FinViz.com||View MJNA Investment Charts - StockCharts.com|
|View MJNA Stock Overview & Charts - BarChart||View MJNA User Generated Charts - Trading View|
Medical Marijuana, Inc. Reports $20.7 Million in Revenue in Q2 2019, Up 30% Year-Over-Year in Financial Results
Posted on Thursday August 15, 2019
SAN DIEGO , Aug. 15, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's ...
Medical Marijuana, Inc. Announces Second Quarter Filing Date and Schedules Investor Conference Call for August 15, 2019
Posted on Monday August 12, 2019
Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that the Company will file its second quarter financial and operational results on August 14 and will host an investor conference call at 4:30 PM ET on Thursday, Aug. 15, to discuss earnings for the quarter ending June 30, 2019. Medical Marijuana, Inc. CEO Dr. Stuart Titus and COO Blake Schroeder will provide updates on the financial and operational performance of the Company in the second quarter of 2019, share recent research and development progress, and discuss where the company is headed for the remainder of the year and in the future.
Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Announces Launch of Watermelon-Flavored CBD Gummies
Posted on Wednesday August 07, 2019
SAN DIEGO , Aug. 7, 2019 /PRNewswire/ -- Medical Marijuana, Inc . (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived ...
CBD And Chemotherapy-Induced Peripheral Neuropathy: What Science Tells Us
Posted on Tuesday August 06, 2019
A recent study revealed research findings around chemotherapy-induced peripheral neuropathy, or CIPN, and the potential for CBD as a treatment. The study, conducted by Kannalife, a company in the Medical Marijuana Inc (OTC: MJNA) portfolio, and published in the Journal of Molecular Neuroscience, showed that both CBD and the company's proprietary CBD-like molecule, KLS-13019, had protective action on the mitochondrial exchanger known to increase calcium levels — and therefore neuropathic pain — in patients taking the chemotherapy drug paclitaxel. It's actually a greater difference in potency," said Dr. Doug Brenneman, Kannalife's lead scientist.